Atlas Trials

Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

RecordFirmDate
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma (NCT06728618)Shanghai Zhongshan Hospital2024-12-01

Track Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.